Delivery Order SPE2DB20D3103-SPE2DB25FQ3S6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,867.32 to AmerisourceBergen Drug Corp for the supply of Fosinopril Sodium 40 mg tablets (90-count) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fosinopril Sodium 40 mg tablets (90-count supply) valued at $17,754.72 under a firm fixed price contract type. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fosinopril Sodium 40 mg tablets in a quantity of 1,000 units under a firm fixed-price contract valued at $1,643.45. The award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. This is a non-set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also designated as the place...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,359.82 firm fixed-price contract is for the supply of 4,565,908,975 units of Fosinopril Sodium 40 mg tablets to support military treatment facilities. The contract has an ultimate completion date of September 24, 2024 and is not designated as a set-aside. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen is a...
- This federal contract award, valued at $1,733.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,832,582 units of Fosinopril Sodium 40 mg tablets, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. The contract is not designated with a set-aside requirement, indicating open...
- This is a $2,392.53 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the supply of Fosinopril Sodium 10 mg tablets in 1,000 count packages. The contract has a period of performance through June 17, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $7,830.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fosinopril Sodium 20 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside contract represents a competitively awarded transaction for pharmaceutical supply to support federal healthcare requirements. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,219.44 firm fixed-price delivery order is for the supply of Fosinopril Sodium 40 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,654.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of Fosinopril Sodium 40 mg tablets to support military treatment facilities,...
- This federal contract award, valued at $2,406.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Fosinopril Sodium 40 mg tablets in 90 count packages. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves federal government...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3S6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,065.70 to AmerisourceBergen Drug Corp for 1,000 tablets of Fosinopril Sodium 40 mg, an ACE inhibitor commonly used to treat hypertension. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a broad portfolio of generic and brand-name medications, vaccines, and specialized medical supplies. The company's large IDC with DLA Troop Support Medical enables flexible procurement of pharmaceutical products to support Defense Health Agency requirements and other government healthcare systems globally. This particular delivery order represents a routine fulfillment under that umbrella contract, reflecting AmerisourceBergen's established role as a major federal pharmaceutical vendor operating through competitive, non-set-aside contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/17/25 |